Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease
Aim. To assess biomarkers of T2-inflammation in patients with chronic obstructive pulmonary disease (COPD). Materials and methods. We examined 173 adult outpatients (80% male, age 40–89 yrs) with COPD. Lung function tests were assessed by using the Spirograph 2120 (Vitalograph, UK). Blood eosinop...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2025-01-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/646535/193867 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850192262543179776 |
|---|---|
| author | Galina R. Sergeeva Alexander V. Emelyanov Evgeniya V. Leshenkova Antonina A. Znakhurenko |
| author_facet | Galina R. Sergeeva Alexander V. Emelyanov Evgeniya V. Leshenkova Antonina A. Znakhurenko |
| author_sort | Galina R. Sergeeva |
| collection | DOAJ |
| description | Aim. To assess biomarkers of T2-inflammation in patients with chronic obstructive pulmonary disease (COPD).
Materials and methods. We examined 173 adult outpatients (80% male, age 40–89 yrs) with COPD. Lung function tests were assessed by using the Spirograph 2120 (Vitalograph, UK). Blood eosinophils (Eos) were measured by automatic haemoanalyser. Atopic status was determined by serum specific immunoglobulin E to common inhalant allergens. Fractional exhaled nitric oxide (FeNO) was measured by a chemiluminescence analyzer (LR4100, Logan Research, Rochester, UK). Symptoms and quality of life were assessed by using Russian versions of St. George's Respiratory Questionnaire (SGRQ) and COPD Assessment Test. Statistical analyses were performed with Statistica ver. 10.0 (StatSoft, Inc., USA).
Results. The most frequent marker was blood Eos ≥150 cell/μl (36%), less often was elevated level FeNO≥20 ppb, allergy was rare (5%) and house dust mites were the common allergen. T2-associated diseases (allergic rhinitis, nasal polyposis, atopic dermatitis) were diagnosed in 7% patients.
Conclusion. Forty percent of patients with COPD without concomitant asthma have markers of T2-airway inflammation in a real clinical practice. The most frequent marker was blood Eos≥150 cell/μl that was associated with rate of COPD exacerbation. Frequency of concomitant T2-diseases (allergic rhinitis, nasal polyps, atopic dermatitis) was low. |
| format | Article |
| id | doaj-art-2ae4c298f95749bcabc669f7eb004bc1 |
| institution | OA Journals |
| issn | 0040-3660 2309-5342 |
| language | Russian |
| publishDate | 2025-01-01 |
| publisher | "Consilium Medicum" Publishing house |
| record_format | Article |
| series | Терапевтический архив |
| spelling | doaj-art-2ae4c298f95749bcabc669f7eb004bc12025-08-20T02:14:38Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422025-01-0197325025610.26442/00403660.2025.03.20314778661Markers of T2-airway inflammation in patients with chronic obstructive pulmonary diseaseGalina R. Sergeeva0https://orcid.org/0000-0003-1544-4336Alexander V. Emelyanov1https://orcid.org/0000-0002-8574-6869Evgeniya V. Leshenkova2https://orcid.org/0000-0003-4616-3166Antonina A. Znakhurenko3https://orcid.org/0009-0008-3218-3397Mechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversityAim. To assess biomarkers of T2-inflammation in patients with chronic obstructive pulmonary disease (COPD). Materials and methods. We examined 173 adult outpatients (80% male, age 40–89 yrs) with COPD. Lung function tests were assessed by using the Spirograph 2120 (Vitalograph, UK). Blood eosinophils (Eos) were measured by automatic haemoanalyser. Atopic status was determined by serum specific immunoglobulin E to common inhalant allergens. Fractional exhaled nitric oxide (FeNO) was measured by a chemiluminescence analyzer (LR4100, Logan Research, Rochester, UK). Symptoms and quality of life were assessed by using Russian versions of St. George's Respiratory Questionnaire (SGRQ) and COPD Assessment Test. Statistical analyses were performed with Statistica ver. 10.0 (StatSoft, Inc., USA). Results. The most frequent marker was blood Eos ≥150 cell/μl (36%), less often was elevated level FeNO≥20 ppb, allergy was rare (5%) and house dust mites were the common allergen. T2-associated diseases (allergic rhinitis, nasal polyposis, atopic dermatitis) were diagnosed in 7% patients. Conclusion. Forty percent of patients with COPD without concomitant asthma have markers of T2-airway inflammation in a real clinical practice. The most frequent marker was blood Eos≥150 cell/μl that was associated with rate of COPD exacerbation. Frequency of concomitant T2-diseases (allergic rhinitis, nasal polyps, atopic dermatitis) was low.https://ter-arkhiv.ru/0040-3660/article/viewFile/646535/193867chronic obstructive pulmonary diseasebiomarkerst2-inflammation |
| spellingShingle | Galina R. Sergeeva Alexander V. Emelyanov Evgeniya V. Leshenkova Antonina A. Znakhurenko Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease Терапевтический архив chronic obstructive pulmonary disease biomarkers t2-inflammation |
| title | Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease |
| title_full | Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease |
| title_fullStr | Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease |
| title_full_unstemmed | Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease |
| title_short | Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease |
| title_sort | markers of t2 airway inflammation in patients with chronic obstructive pulmonary disease |
| topic | chronic obstructive pulmonary disease biomarkers t2-inflammation |
| url | https://ter-arkhiv.ru/0040-3660/article/viewFile/646535/193867 |
| work_keys_str_mv | AT galinarsergeeva markersoft2airwayinflammationinpatientswithchronicobstructivepulmonarydisease AT alexandervemelyanov markersoft2airwayinflammationinpatientswithchronicobstructivepulmonarydisease AT evgeniyavleshenkova markersoft2airwayinflammationinpatientswithchronicobstructivepulmonarydisease AT antoninaaznakhurenko markersoft2airwayinflammationinpatientswithchronicobstructivepulmonarydisease |